Mesalamine 4 g/60mL (Mesalamine SUSPENSION) 4 g/60mL

Mesalamine 4 g/60mL is a rectal suspension used for managing inflammatory conditions. This formulation is designed for targeted relief and is available in a convenient 60 mL bottle.

Strength

4 g/60mL

Pack Size

28 BOTTLE, DISPENSING in 1 CARTON (21922-045-49) / 60 mL in 1 BOTTLE, DISPENSING (21922-045-01)

Manufacturer / TM Owner

Encube Ethicals Private Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mesalamine 4 g/60mL is commonly used for the treatment of inflammatory bowel conditions. It is often prescribed for conditions like ulcerative colitis, where localized relief is beneficial. This medication works by reducing inflammation in the colon, helping to alleviate symptoms such as pain and discomfort.

Side Effects

When used as directed, Mesalamine 4 g/60mL may help reduce inflammation and associated symptoms. Some users may experience common effects such as mild abdominal discomfort or changes in bowel movements. It is important to follow the prescribed regimen for optimal results.

Precautions & Warnings

Mesalamine 4 g/60mL should be used with caution, especially if you have a history of allergic reactions to similar medications. It is important to consult with a healthcare provider before starting this treatment, particularly if you have any pre-existing conditions or are taking other medications.

Avoid Interactions

Mesalamine 4 g/60mL may interact with certain medications, including other inflammatory bowel disease treatments. It is advisable to avoid alcohol while using this medication, as it may increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Mesalamine 4 g/60mL is used for managing inflammatory conditions in the colon, such as ulcerative colitis.

Mesalamine 4 g/60mL is a rectal suspension and should be administered as directed by a healthcare provider.

Common effects may include mild abdominal discomfort or changes in bowel movements.

It is important to consult a healthcare provider before combining Mesalamine 4 g/60mL with other medications to avoid potential interactions.

Long-term use should be monitored by a healthcare provider to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.